Overview

Effect of Extended-release Oxymorphone Taking With or Without Food on Cognitive Functioning

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether extended-release oxymorphone hydrochloride taken orally with a high-fat meal, generating an approximately 50% higher Cmax, impacts cognitive functioning, using Cambridge Neuropsychological Test Automated Battery (CANTAB) tests, to a greater extent than when taking under conditions of fasting.
Phase:
Phase 4
Details
Lead Sponsor:
MedVadis Research Corporation
Treatments:
Oxymorphone